Company · CIK 0001354591 · SIC 2860 — Industrial Organic Chemicals
PetLife Pharmaceuticals, Inc. · PTLF
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2018 PForm 4 → | Mar 20, 1:08 pm EDT | Vyvyan CampbellDirector | 305,000 | $4,017.00 | $1,225,185,000 | 1,305,000 | +30.5% | plan? late |
| Aug 17, 2017 AJForm 4 → | Mar 2, 2018, 3:00 pm EST | Ralph T SalvagnoChief Executive Officer, Director, 10% Owner | 7,500,000 | $0.06 | $300,000 | 17,450,000 | — | plan? late |
| Aug 17, 2017 JForm 4 → | Mar 2, 2018, 3:00 pm EST | Vyvyan CampbellDirector | 2,000,000 | — | — | 1,000,000 | — | plan? late |
| Feb 23, 2017 AForm 4 → | Mar 27, 6:15 am EDT | Ralph T SalvagnoCEO, Director, 10% Owner | 11,160,000 | $0.50 | $5,580,000 | 12,300,000 | — | plan? late |
| Oct 27, 2016 AJForm 4 → | Mar 2, 2018, 3:00 pm EST | Ramana VivekChief Medical Officer | 3,000,000 | $0.67 | $670,000 | 1,000,000 | — | plan? late |
| Oct 27, 2016 AForm 4 → | Mar 24, 2017, 7:47 pm EDT | Vyvyan CampbellDirector, 10% Owner | 10,684,555 | $0.50 | $5,342,278 | 9,484,555 | — | plan? late |
| Dec 29, 2015 PForm 4 → | Mar 27, 2017, 6:15 am EDT | Ralph T SalvagnoCEO, Director, 10% Owner | 1,140,000 | $0.5205 | $593,400 | 1,140,000 | — | plan? late |
| May 30, 2015 PForm 4 → | Mar 24, 2017, 7:47 pm EDT | Vyvyan CampbellDirector, 10% Owner | 408,680 | $0.846 | $345,745 | 1,608,680 | +34.1% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2016 AForm 4 → | Mar 27, 2017, 6:15 am EDT | Ralph T SalvagnoCEO, Director, 10% Owner | 2,000,000 | — | — | 2,000,000 | — | late |